India Adult Vaccine Market: Only 2%-5% of Urban Adults Vaccinated, Despite 16.2% Elderly Population

DELHI, India - Oct. 18, 2024 - PRLog -- India, recognized as a global leader in vaccine production, manufactures approximately 60% of the world's vaccines as of 2023. However, despite this leadership, the nation struggles with adult vaccination coverage, particularly in urban areas. With 16.2% of the adult population being elderly, only 2%-5% of urban adults are vaccinated, underscoring the critical need for better access and awareness in adult immunization programs.

Diverse Vaccine Adoption Across APAC
In the Asia-Pacific (APAC) region, the adult vaccine market is influenced by factors such as seasonal influenza, hepatitis, and the rising demand for HPV vaccines for cancer prevention. COVID-19 vaccines, especially booster doses, also remain a priority. However, disparities in healthcare infrastructure across the region lead to uneven vaccine coverage.

East Asian countries like Japan and South Korea have established successful adult vaccination programs with high coverage rates. In contrast, Southeast Asia exhibits varied adoption, with Singapore and Thailand leading the way, while South Asian nations, including India and Pakistan, are gradually improving despite challenges like healthcare infrastructure and public awareness.

Cervical Cancer and the India Adult Vaccine Market
Cervical cancer remains a major public health concern in India, where one woman dies every seven minutes from this preventable disease. India accounts for 21% of global cervical cancer deaths, with around 125,000 new cases and 75,000 deaths annually. The high cost of HPV vaccines, often priced at INR 4,000 per dose, limits access for low- and middle-income groups.

Challenges and Growth Drivers in India's Adult Vaccine Market
India's adult vaccine market faces several challenges, including:

1. Low Investment in Adult Vaccines: Less than 2% of pharmaceutical expenditure is allocated to adult vaccines, indicating a lack of prioritization.
2. Post-Pandemic Decline: After peaking during the COVID-19 pandemic, adult vaccination rates have yet to return to pre-pandemic levels.
3. Vaccine Hesitancy: Misinformation and low awareness contribute to hesitancy among adults.
4. Operational Barriers: Vaccine delivery and limited access points create challenges for adult immunization programs.

Despite these challenges, the market shows growth potential, driven by rising demand for vaccines such as influenza, pneumococcal, hepatitis, and COVID-19.

Key Market Players and Opportunities
Leading companies in India's vaccine market include Merck Group, Pfizer Ltd., Sanofi Pasteur, Serum Institute of India, and Bharat Biotech. As India continues to innovate and expand vaccine production, new opportunities for both domestic and global players are expected to emerge.

For more insights into the India Adult Vaccine Market, access the India Adult Vaccine Market Report - Global Vaccination Coverage, Demand, Opportunities, Pipeline Vaccines, and Competitive Analysis (https://www.makreo.com/report/india-adult-vaccine-market-...) comprehensive report from Makreo Research.